Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

    Investing

    • Inheritance TaxInheritance Tax
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

News & Insights

Stock News Highlights

27th January 2023

27th January 2023

UK markets UK markets were little changed this week with the FTSE 100 Index falling by 0.1% to trade at 7,770 points at the…

20th January 2023

20th January 2023

UK markets pulled back from near record highs this week with the FTSE 100 Index falling by 1.05% to trade at 7,775 points at…

13th January 2023

13th January 2023

UK markets had another positive week with the FTSE 100 Index hitting a four-year high, rising by 2.1% to trade at 7,840 points at…

6th January 2023

6th January 2023

UK markets made a positive start to the new year, with the FTSE 100 index rising by 2.25% to trade at 7,650 points at…

More Stock News Highlights

Market News

GSK provides update on US FDA advisory committee review of Blenrep (belantamab mafodotin-blmf) combinations for patients with relapsed/refractory multiple myeloma

18 July 2025

RECKITT ANNOUNCES AGREEMENT TO DIVEST ESSENTIAL HOME

18 July 2025

ASML reports €7.7 billion total net sales and €2.3 billion net income in Q2 2025

18 July 2025

James Cropper plc

17 July 2025

SSE plc – Q1 Trading Statement

17 July 2025

Hansa Trust – Annual Financial Report

16 July 2025

AstraZeneca Release Update on Anselamimab

16 July 2025

More Market News

Insights

Blog

Stock Listings

Current Research Coverage List

Current Research Coverage List

James Sharp undertakes independent research on a selection of securities and funds. Our list as shown here is updated on a quarterly basis. Risk...

Home > News & Insights

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG